Category: Uncategorized

Frank Mayer Unveils New Website Featuring Custom Digital Kiosk and Retail Display Solutions The revamped website showcases the company’s custom solutions for enterprise and growth-oriented brands.

Texas Senate Passes Bill to Ban Hemp THC: ‘These People Are Not Good People,’ Senator Says Texas Lt. Gov. Dan Patrick, who supports the bill, said products with intoxicating hemp derivatives are ‘a poison in our public.’

Nebraska Attorney General Sends Cease-and-Desist Letters to 104 Omaha Shops Selling THC Products Mike Hilgers said he plans to pursue litigation and seek penalties to the full extent of the law for companies that don’t remove the products from their shelves.

Texas Lieutenant Governor ‘Carded’ at Compliant Austin-Based Hemp Retailer The Happy Cactus team asked Lt. Gov. Dan Patrick for his ID and refused to sell him products containing more than the allowable serving size.

Teamsters Ratifies 1st Cannabis Union Contract in Maryland for Ascend Workers Cannabis dispensary workers at Ascend blaze a trail for industry-leading standards in the state.

Cannabis Rescheduling Participant Boots Perkins Coie as Counsel for DEA Hearing Process John J. Mulrooney, the DEA’s chief administrative law judge, granted Perkins Coie’s motion to withdraw as counsel for Hemp for Victory.

North Carolina Representative Files Cannabis Legalization Bill for Adults 21+ House Rep. Jordan Lopez introduced the Marijuana Legalization and Reinvestment Act to regulate and tax licensed dispensary sales.

Trulieve Opening Medical Cannabis Dispensary in North Miami Beach The new store is the company’s 163rd cannabis retail facility in Florida.

SNDL Reports Q4 and Full Year 2024 Financial and Operational Results The company reported record full-year net revenue, gross profit and gross margin, as well as positive cash flow and free cash flow.

DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development In ‘huge first,’ systemically absorbed oral cannabinoid AJA001 from Charlotte’s Web genetics receives FDA clearance for Phase 2 clinical trials.